HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-term portal hypertension in the rat by means of triple stenotic ligation of the portal vein].

AbstractOBJECTIVE:
To improve the technique of stenosing ligation of the portal vein, frequently used to obtain a prehepatic portal hypertension model in the rat, by increase the initial resistance to the blood flow.
METHODS:
In this experimental work portal stenosis by three equidistant stenosing ligatures which are fixed in a plastic guide is proposed as an alternative technique.
RESULTS:
Triple stenosing ligation of the portal vein does not produce mortality and causes splenomegaly as well as a larger degree of collateral venous circulation, particularly of splenorenal type, in relation to rats with a simple stenosing ligation.
CONCLUSION:
Increase of the stenosed tract length of the portal vein in the rats with triple ligation increases the initial resistance to the portal flow and then the posterior evolution would be impaired and this mechanism could be involved in a larger degree of collateral venous circulation.
AuthorsG Rodríguez Fabián, G Monterde García, B Diéguez Fernández, M A Aller Reyero, J Arias Pérez
JournalAnales de medicina interna (Madrid, Spain : 1984) (An Med Interna) Vol. 17 Issue 3 Pg. 137-41 (Mar 2000) ISSN: 0212-7199 [Print] Spain
Vernacular TitleHipertensión portal a largo plazo en la rata por triple ligadura estenosante de la vena porta.
PMID10804636 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Analysis of Variance
  • Animals
  • Constriction, Pathologic (etiology)
  • Disease Models, Animal
  • Hypertension, Portal (etiology)
  • Ligation
  • Male
  • Portal Vein (physiology, surgery)
  • Rats
  • Rats, Wistar
  • Reoperation
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: